Arbutus Biopharma's average Accounts Receivable for the
three
months ended in Dec. 2023 was $1.97 Mil. Arbutus Biopharma's Revenue for the
three
months ended in Dec. 2023 was $2.15 Mil.
Hence, Arbutus Biopharma's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 83.95.
The historical rank and industry rank for Arbutus Biopharma's Days Sales Outstanding or its related term are showing as below:
ABUS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.53 Med: 34.1 Max: 156.8
Current: 42.56
During the past 13 years, Arbutus Biopharma's highest Days Sales Outstanding was 156.80. The lowest was 10.53. And the median was 34.10.
ABUS's Days Sales Outstanding is ranked better than 75.11% of 888
companies
in the Biotechnology industry
Industry Median: 72.105
vs ABUS: 42.56
Arbutus Biopharma's Days Sales Outstanding
increased
from Dec. 2022 (23.28) to Dec. 2023 (83.95).
Arbutus Biopharma Days Sales Outstanding Historical Data
The historical data trend for Arbutus Biopharma's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arbutus Biopharma's Days Sales Outstanding
For the Biotechnology subindustry, Arbutus Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arbutus Biopharma's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arbutus Biopharma's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Arbutus Biopharma's Days Sales Outstanding falls into.
Arbutus Biopharma Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arbutus Biopharma (NAS:ABUS) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Arbutus Biopharma Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Arbutus Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Arbutus Biopharma (Arbutus Biopharma) Business Description
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABUS has been successfully added to your 